Breaking News

MilliporeSigma Develops New CRISPR Genome Editing Method

Aims to provide researchers with more experimental options and faster results

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MilliporeSigma has developed a new genome editing tool designed to make CRISPR more efficient, flexible and specific, in an effort to provide researchers with more experimental options and faster results. This new technique, called “proxy-CRISPR,” provides access to previously unreachable areas of the genome, according to the company. Most natural CRISPR systems, found in bacteria, cannot work in human cells without significant re-engineering. However, proxy-CRISPR provides a a ne...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters